Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world studyWei‐Feng Qu, Ying–Hong Shi, Zhen‐Bin Ding et al.|BJS Open|2022Cited by 58
Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective studyGuiqi Zhu, Ying–Hong Shi, Weiren Liu et al.|Molecular Oncology|2021Cited by 44
Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinomaMeng‐Xin Tian, Ying–Hong Shi, Yuan Fang et al.|BMC Medicine|2019Cited by 44
Single-cell and spatial architecture of primary liver cancerPei‐Yun Zhou, Shuang‐Jian Qiu, Cheng Zhou et al.|Communications Biology|2023Cited by 42
Prediction of overall survival in resectable intrahepatic cholangiocarcinoma: IS<sub>ICC</sub>‐applied prediction modelMeng‐Xin Tian, Ying–Hong Shi, Weiren Liu et al.|Cancer Science|2020Cited by 24